Stock ABBV ABBVIE INC.
Add to a list
To use this feature you must be a member
Log inSign up

Company AbbVie Inc.

Equities

ABBV

US00287Y1091

Pharmaceuticals

Market Closed - Nyse
Other stock markets
 04:00:02 2024-04-19 pm EDT 		5-day change 1st Jan Change
166.4 USD +1.06% Intraday chart for AbbVie Inc. +2.54% +7.38%
Apr. 19 Sector Update: Health Care Stocks Advance Late Afternoon MT
Apr. 19 Sector Update: Health Care Stocks Rise Friday Afternoon MT

Business Summary

AbbVie Inc. specializes in therapeutic drug research and development. Its products are intended for treating rheumatoid arthritis, psoriasis, Crohn's disease, thyroid disease, Parkinson's disease, HIV, complications of mucoviscidosis, low testosterone levels, and complications associated with chronic renal disease.

Net sales are distributed geographically as follows: the United States (77.1%), Germany (2.3%), Canada (2%), Japan (1.9%), China (1.7%), France (1.4%), Spain ( 0.9%), Italy (0.9%), Australia (0.9%), Brazil (0.8%), United Kingdom (0.8%) and others (9.3%).

Number of employees: 50,000

Sales per Business

USD in Million2022Weight2023Weight Delta
Immunology
48.1 %
28,924 49.8 % 26,136 48.1 % -9.64%
Neuroscience
14.2 %
6,528 11.2 % 7,717 14.2 % +18.21%
Other
12.6 %
7,991 13.8 % 6,841 12.6 % -14.39%
Oncology
10.9 %
6,577 11.3 % 5,915 10.9 % -10.07%
Aesthetics
9.7 %
5,333 9.2 % 5,294 9.7 % -0.73%
Eye Care
4.4 %
2,701 4.7 % 2,415 4.4 % -10.59%

Sales per region

USD in Million2022Weight2023Weight Delta
United States
77.1 %
45,713 78.7 % 41,883 77.1 % -8.38%
All Other Countries
9.3 %
4,837 8.3 % 5,042 9.3 % +4.24%
Germany
2.3 %
1,340 2.3 % 1,266 2.3 % -5.52%
Canada
2.0 %
1,159 2.0 % 1,076 2.0 % -7.16%
Japan
1.9 %
956 1.6 % 1,008 1.9 % +5.44%
China
1.7 %
912 1.6 % 950 1.7 % +4.17%
France
1.4 %
787 1.4 % 780 1.4 % -0.89%
Spain
0.9 %
506 0.9 % 501 0.9 % -0.99%
Italy
0.9 %
444 0.8 % 484 0.9 % +9.01%
Australia
0.9 %
508 0.9 % 472 0.9 % -7.09%
Brazil
0.8 %
430 0.7 % 439 0.8 % +2.09%
United Kingdom
0.8 %
462 0.8 % 417 0.8 % -9.74%

Managers

Managers TitleAgeSince
Richard Gonzalez CEO
 Chief Executive Officer 70 12-12-31
Scott Reents DFI
 Director of Finance/CFO 57 12-12-31
Robert Michael PSD
 President 53 11-12-31
Thomas Hudson CTO
 Chief Tech/Sci/R&D Officer 62 15-12-31
Azita Saleki-Gerhardt COO
 Chief Operating Officer 60 12-12-31
Todd D. Bosse IRC
 Investor Relations Contact - 21-11-30
Roopal Thakkar PRN
 Corporate Officer/Principal - 02-12-31
Kevin Buckbee AUD
 Comptroller/Controller/Auditor 58 23-02-28
Perry Siatis LAW
 General Counsel - 22-09-30
Carrie Strom PRN
 Corporate Officer/Principal - 20-05-07

Members of the board

Members of the board TitleAgeSince
Roxanne Austin BRD
 Director/Board Member 63 12-12-31
Edward Rapp BRD
 Director/Board Member 66 12-12-31
Frederick Waddell BRD
 Director/Board Member 70 12-12-31
Glenn Tilton BRD
 Director/Board Member 75 12-12-31
Richard Gonzalez CEO
 Chief Executive Officer 70 12-12-31
Thomas Freyman BRD
 Director/Board Member 69 20-05-07
William H. L. Burnside BRD
 Director/Board Member 72 12-12-31
Brett Hart BRD
 Director/Board Member 54 15-12-31
Robert Alpern BRD
 Director/Board Member 73 12-12-31
Robert Michael PSD
 President 53 11-12-31

Share class

VoteQuantityFree-FloatCompany-owned sharesTotal Float
Stock A 1 1,827,752,337 1,768,404,283 ( 96.75 %) 57,105,354 ( 3.124 %) 96.75 %

Shareholders

NameEquities%Valuation
Vanguard Fiduciary Trust Co.
9.080 %
160,398,331 9.080 % 29 209 M $
BlackRock Advisors LLC
6.295 %
111,194,482 6.295 % 20 249 M $
STATE STREET CORPORATION
4.427 %
78,200,866 4.427 % 14 240 M $
JPMorgan Investment Management, Inc.
2.818 %
49,783,234 2.818 % 9 066 M $
Capital Research & Management Co. (International Investors)
2.547 %
44,988,183 2.547 % 8 192 M $
Geode Capital Management LLC
2.096 %
37,017,486 2.096 % 6 741 M $
Eaton Vance Management
1.927 %
34,048,660 1.927 % 6 200 M $
Capital Research & Management Co. (Global Investors)
1.715 %
30,302,654 1.715 % 5 518 M $
BlackRock Life Ltd.
1.616 %
28,543,244 1.616 % 5 198 M $
Charles Schwab Investment Management, Inc.
1.384 %
24,451,975 1.384 % 4 453 M $
NameEquities%Valuation
Caixa DTVM SA
0.001471 %
415,822 0.001471 % 5 M $
Bram Bradesco Asset Management S/A DTVM
0.000227 %
64,298 0.000227 % 732 313 $
XP Allocation Asset Management Ltda.
0.000004 %
1,119 0.000004 % 12 745 $

Holdings

NameEquities%Valuation
CARISMA THERAPEUTICS, INC.
6.81%
 2,749,855 6.81% 6,242,171 $

Company contact information

AbbVie, Inc.

1 North Waukegan Road

60064-6400, North Chicago

+847 932 7900

http://www.abbvie.com
address AbbVie Inc.(ABBV)

Group companies

NameCategory and Sector
Allergan Norden AB
AbbVie Bahamas Ltd.
AbbVie Biotechnology Ltd.
AbbVie Corp.
AbbVie Endocrine, Inc.
AbbVie GK
AbbVie International SARL
AbbVie Investments SARL
AbbVie Ireland NL BV

Sector

Healthcare
Pharmaceuticals & Medical Research
Pharmaceuticals
Pharmaceuticals
Other Pharmaceuticals

Sales per Business

Sales per region

Ratings for AbbVie Inc.

Trading Rating
Investor Rating
ESG Refinitiv
C+
More Ratings

Analysts' Consensus

Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
29
Last Close Price
166.4 USD
Average target price
184.1 USD
Spread / Average Target
+10.66%
Consensus

EPS Revisions

Estimates Revisions

Quarterly earnings - Rate of surprise

Company calendar

Sector Other Pharmaceuticals

1st Jan change Capi.
ABBVIE INC. Stock AbbVie Inc.
+7.38% 295B
ELI LILLY AND COMPANY Stock Eli Lilly and Company
+24.60% 654B
NOVO NORDISK A/S Stock Novo Nordisk A/S
+24.08% 552B
JOHNSON & JOHNSON Stock Johnson & Johnson
-5.63% 356B
MERCK & CO., INC. Stock Merck & Co., Inc.
+15.37% 319B
ASTRAZENECA PLC Stock AstraZeneca PLC
+3.26% 211B
NOVARTIS AG Stock Novartis AG
+0.78% 206B
PFIZER, INC. Stock Pfizer, Inc.
-9.69% 147B
AMGEN INC. Stock Amgen Inc.
-6.63% 144B
SANOFI Stock Sanofi
-3.20% 116B
Other Pharmaceuticals
  1. Stock Market
  2. Equities
  3. ABBV Stock
  4. Company AbbVie Inc.